Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Menopause hormone therapy and risk of mild cognitive impairment or dementia: a systematic review and meta-analysis 2025-12-22
  2. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study 2012-10-24
  3. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study 2004-06-01

Studies

7 studies carry this tag.

Date range

1998 to 2025

Top journals

  • JAMA 5
  • Neurology 1
  • The Lancet Healthy Longevity 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Menopause hormone therapy and risk of mild cognitive impairment or dementia: a systematic review and meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. The Lancet Healthy Longevity 2025-12-22 Prevention and risk

    No significant association was found between MHT use and risk of mild cognitive impairment or dementia.

  2. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study

    ✓ Peer-reviewed alzhub usefulness score 68 out of 100. Neurology 2012-10-24 Treatments

    Association of HT use and risk of AD may depend on timing of use.

  3. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

    ✓ Peer-reviewed alzhub usefulness score 80 out of 100. JAMA 2004-06-01 How common it is

    For women aged 65 years or older, hormone therapy had an adverse effect on cognition, which was greater among women with lower cognitive function at initiation of treatment.

  4. In the estrogen-alone trial, 47 participants were diagnosed with probable dementia, of whom 28 were assigned to CEE and 19 to placebo (hazard ratio [HR], 1.49; 95% confidence interval [CI], 0.83-2.66).

  5. The mean (SD) time between the date of randomization into WHI and the last Modified Mini-Mental State Examination (3MSE) for all WHIMS participants was 4.05 (1.19) years.

  6. Estrogen replacement therapy for 1 year did not slow disease progression nor did it improve global, cognitive, or functional outcomes in women with mild to moderate AD.

  7. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

    ✓ Peer-reviewed alzhub usefulness score 70 out of 100. JAMA 1998-03-01 Prevention and risk

    Meta-analysis of these studies suggests a 29% decreased risk of developing dementia among estrogen users, but the findings of the studies are heterogeneous.

All topic tags with their study counts